O Brien Greene & Co. Inc bought a new position in shares of M.D.C. Holdings, Inc. (NYSE:MDC – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 4,222 shares of the construction company’s stock, valued at approximately $233,000.
Several other hedge funds and other institutional investors have also modified their holdings of MDC. CWM LLC lifted its position in shares of M.D.C. by 31.7% during the 3rd quarter. CWM LLC now owns 1,447 shares of the construction company’s stock worth $60,000 after buying an additional 348 shares during the period. Ronald Blue Trust Inc. increased its holdings in M.D.C. by 100.0% during the 3rd quarter. Ronald Blue Trust Inc. now owns 640 shares of the construction company’s stock valued at $26,000 after purchasing an additional 320 shares in the last quarter. SG Americas Securities LLC acquired a new stake in M.D.C. during the 3rd quarter valued at $1,091,000. Raymond James Financial Services Advisors Inc. increased its holdings in M.D.C. by 3.8% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 110,424 shares of the construction company’s stock valued at $4,553,000 after purchasing an additional 4,004 shares in the last quarter. Finally, Total Clarity Wealth Management Inc. acquired a new stake in M.D.C. during the 3rd quarter valued at $300,000. Institutional investors own 88.08% of the company’s stock.
M.D.C. Stock Performance
MDC stock opened at $62.98 on Friday. The business’s 50-day moving average price is $62.79 and its two-hundred day moving average price is $54.63. The company has a current ratio of 9.76, a quick ratio of 3.92 and a debt-to-equity ratio of 0.50. The firm has a market cap of $4.73 billion, a PE ratio of 11.93 and a beta of 1.54. M.D.C. Holdings, Inc. has a 1-year low of $36.47 and a 1-year high of $63.00.
Analyst Ratings Changes
A number of research firms recently weighed in on MDC. StockNews.com began coverage on M.D.C. in a report on Saturday. They set a “hold” rating for the company. Evercore ISI cut M.D.C. from an “outperform” rating to an “in-line” rating and raised their price target for the company from $57.00 to $63.00 in a report on Wednesday, January 31st. Finally, Raymond James reissued a “market perform” rating on shares of M.D.C. in a research note on Wednesday, February 7th. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. According to data from MarketBeat.com, M.D.C. presently has a consensus rating of “Hold” and a consensus price target of $52.13.
Get Our Latest Research Report on M.D.C.
Insider Activity
In other news, Director David E. Blackford sold 6,200 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $62.69, for a total value of $388,678.00. Following the sale, the director now directly owns 13,534 shares in the company, valued at $848,446.46. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 23.30% of the company’s stock.
About M.D.C.
M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.
See Also
- Five stocks we like better than M.D.C.
- 5 discounted opportunities for dividend growth investors
- MarketBeat Week in Review – 4/22 – 4/26
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Stocks Leading the U.S. Agriculture Comeback
- Why Invest in 5G? How to Invest in 5G Stocks
- How to Use Put Debit Spreads to Profit From Falling Stocks
Want to see what other hedge funds are holding MDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M.D.C. Holdings, Inc. (NYSE:MDC – Free Report).
Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.